95 related articles for article (PubMed ID: 26809534)
1. [A Case of Small Cell Lung Cancer Treated with Concurrent Chemoradiotherapy with Carboplatin plus Etoposide in a Hemodialysis Patient].
Terashima T; Iwami E; Chubachi S; Ikemura S; Nakajima T; Matsuzaki T; Aoyagi H
Gan To Kagaku Ryoho; 2016 Jan; 43(1):99-101. PubMed ID: 26809534
[TBL] [Abstract][Full Text] [Related]
2. Phase II trial of paclitaxel-topotecan-etoposide followed by consolidation chemoradiotherapy for limited-stage small cell lung cancer: CALGB 30002.
Miller AA; Wang XF; Bogart JA; Hodgson LD; Rocha Lima CM; Radford JE; Vokes EE; Green MR;
J Thorac Oncol; 2007 Jul; 2(7):645-51. PubMed ID: 17607121
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of factors associated with loco-regional failure and survival in limited disease small cell lung cancer patients treated with chemoradiotherapy.
Winther-Larsen A; Hoffmann L; Moeller DS; Khalil AA; Knap MM
Acta Oncol; 2015; 54(9):1574-81. PubMed ID: 26203924
[TBL] [Abstract][Full Text] [Related]
4. Randomized phase II study of concurrent cisplatin/etoposide or paclitaxel/carboplatin and thoracic radiotherapy in patients with stage III non-small cell lung cancer.
Wang L; Wu S; Ou G; Bi N; Li W; Ren H; Cao J; Liang J; Li J; Zhou Z; Lv J; Zhang X
Lung Cancer; 2012 Jul; 77(1):89-96. PubMed ID: 22418243
[TBL] [Abstract][Full Text] [Related]
5. Successful chemotherapy for small-cell lung cancer in an elderly patient undergoing continuous ambulatory peritoneal dialysis.
Tanizawa K; Fukunaga K; Okumura N; Sugimura M; Tanaka E; Hajiro T; Sakuramoto M; Minakuchi M; Hashimoto S; Yasuda T; Kaji Y; Ikezoe K; Sato E; Nakajima T; Taguchi Y
Intern Med; 2010; 49(12):1179-83. PubMed ID: 20558939
[TBL] [Abstract][Full Text] [Related]
6. Chemoradiotherapy for poor-risk stage III non-small cell lung cancer.
Lau DH; Ryu JK; Gandara DR
Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-110-S12-112. PubMed ID: 9331133
[TBL] [Abstract][Full Text] [Related]
7. Phase II study of consolidation paclitaxel after concurrent chemoradiation in poor-risk stage III non-small-cell lung cancer: SWOG S9712.
Davies AM; Chansky K; Lau DH; Leigh BR; Gaspar LE; Weiss GR; Wozniak AJ; Crowley JJ; Gandara DR;
J Clin Oncol; 2006 Nov; 24(33):5242-6. PubMed ID: 17114656
[TBL] [Abstract][Full Text] [Related]
8. A phase II study of carboplatin, etoposide, and exisulind in patients with extensive small cell lung cancer: CALGB 30104.
Govindan R; Wang X; Baggstrom MQ; Burdette-Radoux S; Hodgson L; Vokes EE; Green MR;
J Thorac Oncol; 2009 Feb; 4(2):220-6. PubMed ID: 19179900
[TBL] [Abstract][Full Text] [Related]
9. Use of G-CSF during concurrent chemotherapy and thoracic radiotherapy in patients with limited-stage small-cell lung cancer safety data from a phase II trial.
Sheikh H; Colaco R; Lorigan P; Blackhall F; Califano R; Ashcroft L; Taylor P; Thatcher N; Faivre-Finn C
Lung Cancer; 2011 Oct; 74(1):75-9. PubMed ID: 21353720
[TBL] [Abstract][Full Text] [Related]
10. [Combination chemotherapy with carboplatin and etoposide against lung adenocarcinoma in a patient undergoing hemodialysis: a case report].
Yanagawa H; Takishita Y; Bando H; Shinohara T; Tanaka H; Sumitani H
Gan To Kagaku Ryoho; 1993 Dec; 20(15):2409-11. PubMed ID: 8259862
[TBL] [Abstract][Full Text] [Related]
11. Paclitaxel, carboplatin, and extended schedule etoposide in the treatment of small cell lung carcinoma.
Hainsworth JD; Stroup SL; Greco FA
Cancer; 1996 Jun; 77(12):2458-63. PubMed ID: 8640693
[TBL] [Abstract][Full Text] [Related]
12. Phase III study of pemetrexed plus carboplatin compared with etoposide plus carboplatin in chemotherapy-naive patients with extensive-stage small-cell lung cancer.
Socinski MA; Smit EF; Lorigan P; Konduri K; Reck M; Szczesna A; Blakely J; Serwatowski P; Karaseva NA; Ciuleanu T; Jassem J; Dediu M; Hong S; Visseren-Grul C; Hanauske AR; Obasaju CK; Guba SC; Thatcher N
J Clin Oncol; 2009 Oct; 27(28):4787-92. PubMed ID: 19720897
[TBL] [Abstract][Full Text] [Related]
13. A Phase I study of chemoradiotherapy with use of involved-field conformal radiotherapy and accelerated hyperfractionation for Stage III non-small cell lung cancer: WJTOG 3305.
Tada T; Chiba Y; Tsujino K; Fukuda H; Nishimura Y; Kokubo M; Negoro S; Kudoh S; Fukuoka M; Nakagawa K; Nakanishi Y
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):327-31. PubMed ID: 22079726
[TBL] [Abstract][Full Text] [Related]
14. Phase I and pharmacologic study of sequential topotecan-carboplatin-etoposide in patients with extensive stage small cell lung cancer.
Miller AA; Al Omari A; Murry DJ; Case D
Lung Cancer; 2006 Dec; 54(3):379-85. PubMed ID: 17049403
[TBL] [Abstract][Full Text] [Related]
15. Concurrent cisplatin-etoposide chemotherapy plus thoracic radiotherapy for limited-stage small cell lung cancer. Japanese Lung Cancer Chemotherapy Group in Japanese Clinical Oncology Group.
Ariyoshi Y; Fukuoka M; Furuse K; Saijo N; Ikegami H; Nishiwaki Y; Tamura T; Shimoyama M; Suemasu K
Jpn J Clin Oncol; 1994 Oct; 24(5):275-81. PubMed ID: 7967106
[TBL] [Abstract][Full Text] [Related]
16. Double-cycle, high-dose ifosfamide, carboplatin, and etoposide followed by peripheral blood stem-cell transplantation for small cell lung cancer.
Iwasaki Y; Nagata K; Nakanishi M; Natuhara A; Kubota Y; Ueda M; Arimoto T; Hara H
Chest; 2005 Oct; 128(4):2268-73. PubMed ID: 16236883
[TBL] [Abstract][Full Text] [Related]
17. [Weekly paclitaxel and carboplatin with concurrent three dimensional conformal radiotherapy for locally advanced non small cell lung cancer].
Wang J; Pang QS; Wang P; Wang J; Wang W
Zhonghua Zhong Liu Za Zhi; 2007 Oct; 29(10):769-72. PubMed ID: 18396691
[TBL] [Abstract][Full Text] [Related]
18. Carboplatin/etoposide/radiation plus escalating doses of paclitaxel in stage III non-small cell lung cancer: a preliminary report.
Bonomi P; Faber LP; Recine D; Lincoln S
Semin Oncol; 1995 Aug; 22(4 Suppl 9):42-7. PubMed ID: 7644927
[TBL] [Abstract][Full Text] [Related]
19. Chemoradiotherapy in non-small cell lung cancer: paclitaxel/carboplatin/radiotherapy in regionally advanced disease.
Belani CP; Aisner J; Bahri S; Jett J; Day R; Capazolli MJ; Hiponia D; Engstrom C
Semin Oncol; 1996 Dec; 23(6 Suppl 16):113-6. PubMed ID: 9007136
[TBL] [Abstract][Full Text] [Related]
20. Carboplatin plus etoposide for extensive stage small-cell lung cancer: an experience with AUC 6 doses of carboplatin.
Yilmaz U; Polat G; Anar C; Halilcolar H
Indian J Cancer; 2011; 48(4):454-9. PubMed ID: 22293260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
